Andrew Brooks, who developed a Coronavirus spit test, dies at 51

After working at the University of Rochester Medical Center for four years, he returned to New Jersey to work at Rutgers and, in 2009, joined the Cell and DNA Repository, a university-owned company that provides data management and analysis for biological research. .

Dr. Brooks became the company’s chief operating officer and discovered that he had a talent for the business side of science. He increased the company from just a few dozen employees to almost 250, working with almost every major pharmaceutical company, among other customers.

“Most of the scientists I know are not interested in, or are incidentally interested in, commercializing what they do,” said Dr. Jay Tischfield, professor at Rutgers and chief executive of the repository. “Andy understood that if you want something to come out and be used, you have to be a player. You cannot trust other people. “

In 2018, the company, then called Rutgers University Cell and DNA Repository Infinite Biologics, decided to go public, with Dr. Brooks as the new chief executive. The university agreed, but maintained a significant stake in the new company, now called Infinity Biologix.

The resources and experience he has accumulated in the repository made it relatively easy for Dr. Brooks to develop the coronavirus spit test, which he did in partnership with two other companies, Spectrum Solutions and Accurate Diagnostics Labs.

Dr. Brooks was used to doing genetic testing through saliva, and Dr. Tischfield said “it was not rocket science” to adapt these techniques to extract RNA from the coronavirus. The company still had thousands of tubes on hand that it could use to collect samples.

After FDA approval, Dr. Brooks faced a different challenge: scale. He needed a lot more equipment and staff, immediately, to produce the tests and process the results. But a conducive phone call from the White House offering help and a multi-million dollar loan from Dr. Tischfield allowed the company to add additional analytical equipment quickly and almost double its workforce almost overnight.

Source